Clinical trials
Pediatric Cancer clinical trials
Below are recruiting pediatric cancer clinical trials, each written for real people, not researchers. We’re tracking 148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04262830Recruiting
Heart scans to predict future heart failure after chemotherapy
This trial uses detailed heart imaging (a special MRI scan) to see how chemotherapy may have affected your heart and to predict who could develop heart failure later. If you qualify, it may help your care team better monitor your heart health over time.
San Diego, CaliforniaAges 13–39 - NCT04934293Recruiting
Virtual reality support during proton radiation for children
This trial tests whether virtual reality (VR) can be used safely and comfortably for children receiving proton radiation. It aims to improve the experience of treatment by using a VR helmet during radiotherapy sessions.
NiceAges 7–18 - NCT05275881Recruiting
Virtual reality during procedures for young blood or cancer patients
This trial tests whether using virtual reality (VR) during certain procedures can make them easier for children, teens, and young adults with blood or cancer-related conditions. Participants must be able to safely use a VR headset and be willing to take part.
PoitiersAges 7–24 - NCT05309746Recruiting
Save ovarian tissue before cancer treatment
This trial studies freezing (cryopreserving) ovarian tissue before treatment that may permanently affect fertility and hormone production. You might consider it if you are planning surgery, chemotherapy, or radiation soon and want to preserve future options.
Chicago, IllinoisAges Up to 30 years - NCT05316922RecruitingPhase 3
Lowering thyroid hormone during radiation to prevent low thyroid
This study tests whether using treatment to keep thyroid-stimulating signals low during radiation to the thyroid area can help prevent a treatment-related drop in thyroid function in children. It is aimed at kids with certain cancers whose radiation plan includes thyroid tissue.
MilanAges Any age - NCT05454618Recruiting
Deciding to join a pediatric cancer treatment trial
This study looks at the decision-making process for parents (or legal guardians) when their child is newly diagnosed with cancer and might consider enrolling in a treatment trial. It may help improve how families are informed and supported when making these choices.
Memphis, TennesseeAges Any age - NCT05512169Recruiting
Genetic study in Indian children with newly diagnosed leukemia
This study looks at genetic (DNA) differences to understand acute lymphoblastic leukemia (ALL) in Indian children and how treatments may fit better. You may be able to join if your child is newly diagnosed, meets the study’s treatment plan rules, and provides consent.
New DelhiAges 1–18 - NCT05789901Recruiting
Using a Facebook chatbot to share health information
This study tests whether a Facebook Messenger chatbot can provide helpful health information for different conditions. You may help researchers check if people can use the chatbot and understand the information.
Montreal, QuebecAges 14 years+ - NCT05863910Recruiting
Real-world study of medical cannabis use in children
This study looks at how medical cannabis is used for children and teens in everyday life, by collecting information through online questionnaires. It may help doctors and families better understand which uses are common and how people experience them.
Winnipeg, ManitobaAges 3–17 - NCT05867186Recruiting
Get fit during childhood cancer treatment and aftercare
This trial tests a “fit to fight” program to help children and teens stay active during and after cancer treatment. It aims to support physical and possibly emotional well-being while treatment is happening, based on whether your care team thinks it’s safe and helpful for you.
Mainz, Rhineland-PalatinateAges 3–21 - NCT05918640RecruitingPhase 1/Phase 2
Lurbinectedin for cancers with specific EWS-related gene fusions
This early-phase study tests lurbinectedin, a chemotherapy medicine, in children and young adults whose solid tumors have a specific “FET fusion” gene change. It may help shrink tumors that have come back or did not respond to prior treatment, depending on the exact fusion type.
Los Angeles, CaliforniaAges 10 years+ - NCT06054295Recruiting
Twin study of childhood brain tumors
This study looks at genetic differences between identical twins where only one twin has a childhood brain or spinal cord tumor. It helps researchers understand why some children get cancer and others don't.
Minneapolis, MinnesotaAges Up to 18 years - NCT06055296Recruiting
Supporting Hispanic families in pediatric cancer clinical trials
This study helps Hispanic families with a child newly diagnosed with cancer understand their options when a clinical trial is offered. It looks at how to better support parents during the informed consent process.
Birmingham, AlabamaAges 18 years+ - NCT06120764Recruiting
Imagery therapy for chemo-related nausea in children
This study tests if guided imagery (a relaxation technique using mental images) can help reduce nausea and vomiting caused by chemotherapy in children ages 7 to 18. It may offer a drug-free way to manage these side effects.
Ankara, AnkaraAges 7–18 - NCT06367556Recruiting
Emotion and stress support for caregivers of children with cancer
This trial offers a program called EASE (Emotion and Symptom-Focused Engagement) to help family caregivers of children with cancer manage their emotions and stress. It aims to see if providing support to caregivers improves their well-being.
Toronto, OntarioAges 18 years+ - NCT06456892RecruitingPhase 1/Phase 2
Immunotherapy plus chemo for children with hard-to-treat rhabdomyosarcoma
This trial tests if adding the immunotherapy drug Pucotenlimab to standard chemotherapy is safe and effective for children and teens with a type of muscle cancer (rhabdomyosarcoma) that is hard to treat. It may offer a new option for patients whose tumors are difficult to remove with surgery alone.
Guangzhou, GuangdongAges 1–18 - NCT06720064Recruiting
Chlorhexidine dressing care for port and central catheters in children
This trial tests whether a special care bundle with a germ-killing dressing can reduce infections in children with port or central line catheters. It may help keep your child safer during treatment.
IzmirAges 1–17 - NCT06836492RecruitingPhase 3
Risk-based treatment study for children with rhabdomyosarcoma
This study tests different treatment plans for children with rhabdomyosarcoma based on their individual risk factors. It aims to find the best therapy for each child, potentially improving outcomes.
Guangzhou, GuangdongAges birth–18 years - NCT06857292RecruitingPhase 2
A study of a new medicine to prevent fever in children on chemotherapy
This study tests a new medicine called Telpegfilgrastim to help prevent fever from low white blood cell counts in children (14–17) with certain cancers who are getting strong chemotherapy. It aims to see if the medicine is safe and works well.
Guangzhou, GuangdongAges 14–18 - NCT07188311Recruiting
Study of pucotenlimab with lenvatinib and chemo for relapsed hepatoblastoma in children
This trial tests a combination of an immunotherapy (pucotenlimab), a targeted therapy (lenvatinib), and chemotherapy for children with advanced or relapsed hepatoblastoma that hasn't responded to prior treatment. The goal is to see if this combination can help shrink or control the tumor.
Guangdong, GuangzhouAges 2–18 - NCT07323069Recruiting
Nurse-led sleep program for children with cancer
This trial tests a special nurse-led program to help children with cancer sleep better. It includes simple steps to improve sleep and is designed for kids who are between 6 and 12 years old and currently getting cancer treatment.
Kowloon BayAges 6–12 - NCT07502885Recruiting
Study of walking in children with bone or soft tissue tumors
This study looks at how children with certain bone or soft tissue tumors walk after orthopedic surgery. It aims to understand and improve their movement and recovery.
Memphis, TennesseeAges 5–20 - NCT07506239Recruiting
Laser therapy for low-grade brain tumors in young people
This trial tests a laser treatment called LITT for low-grade glioma (a type of brain tumor) that has come back or is growing despite prior treatment. It aims to see if the laser is safe and effective in young people aged 2 to 25.
San Francisco, CaliforniaAges 2–25 - NCT07420101Recruiting
Reducing scan anxiety in caregivers with meditation
This study tests if meditation programs can help ease the anxiety caregivers feel when a loved one with cancer has a routine scan. You will be asked to follow a meditation program and possibly eat a raisin as part of a mindfulness exercise.
Hartford, ConnecticutAges 18 years+
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatric cancer?
- Yes. Clin2 currently lists 148 recruiting pediatric cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatric cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatric cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Beyond the search
We also like to point to nonprofits doing real good in this area. We aren’t affiliated with them — we just admire the work.
- Children’s Oncology Support FundChildren with cancer and the families caring for them.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.